Lyme alternatiivravi OÜ

Active Registry code 16762290 OÜ Tartu linn Registered 20 Jun 2023
Compare

Lyme alternatiivravi OÜ is a OÜ based in Tartu linn, registry code 16762290, status: active. Main activity: Other human health activities n.e.c.. There is no EMTA tax data for this company on the site.

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2023 – 2025
Net profit, € 2025: 6 € · +500.0% vs 2024 · industry median 1 071 € · above 35% of the industry
05001 0001 5002 0002023 Company: 35 € Industry median: 1 745 €20232024 Company: 1 € Industry median: 1 621 €20242025 Company: 6 € Industry median: 1 071 €202505001 0001 5002 0002023 Company: 35 € Industry median: 1 745 €20232024 Company: 1 € Industry median: 1 621 €2025 Company: 6 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 2 483 € · −7.2% vs 2024
01 0002 0003 0002023 Company: 2 875 €20232024 Company: 2 675 €20242025 Company: 2 483 €202501 0002 0003 0002023 Company: 2 875 €20232024 Company: 2 675 €2025 Company: 2 483 €2025
Equity, € 2025: 52 € · +13.0% vs 2024
02040602023 Company: 45 €20232024 Company: 46 €20242025 Company: 52 €202502040602023 Company: 45 €20232024 Company: 46 €2025 Company: 52 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 220250.00.51.01.52.02023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — 6 0 2 483 52 0
2024 — 1 0 2 675 46 0
2023 — 35 0 2 875 45 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Return on equity (ROE)
11.5 %
Net profit / equity
Return on assets (ROA)
0.2 %
Net profit / assets
Equity ratio
2.1 %
Equity / assets
Debt ratio
97.9 %
Liabilities / assets
Current ratio
0.04
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 24 Aug 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 May 2025 Company’s own e-Äriregister
2023 20 Jun 2023 – 31 Dec 2023 14 Aug 2024 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 86909Other human health activities n.e.c. Main

Rulings 3

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50231079 / M1
21 Jul 2024
 Warning of deletion from the register: annual report not filed 24 Oct 2024 Deficiencies eliminated
15 Aug 2024
 PDF
Ä 50231079 / 2
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50231079
20 Jun 2023
 First entry In force
20 Jun 2023
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data